Schubert & CO Ligand Pharmaceuticals Inc Transaction History

Schubert & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$61.72 - $96.74 $61 - $96	-1 Reduced 12.5%	7 $0
Q3 2022 Oct 21, 2022	BUY	$0.01 - $107.56 $0 - $107	1 Added 14.29%	8 $1,000
Q2 2022 Aug 01, 2022	BUY	$74.52 - $117.06 $372 - $585	5 Added 250.0%	7 $1,000
Q1 2022 May 16, 2022	SELL	$94.99 - $151.56 $94 - $151	-1 Reduced 33.33%	2 $0
Q4 2021 Jan 28, 2022	BUY	$127.69 - $165.85 $383 - $497	3 New	3 $0

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.